HANSEN GWENN (Chief Scientific Officer) sold 5.5% of their position (4.89K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $81.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+3.21K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+3.75K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.86K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−4.80K
Price / share
$16.58
Trade value
$79.55K
% of position
Common Stock
Shares
−98.00
Price / share
$17.37
Trade value
$1.70K
% of position
Net shares
+6.92K
Net value
-$81.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2026 | M · Option Exercise | +3.21K | — | — | 4.2% | 76.75K | 79.96K |
| Common Stock Direct | 1/30/2026 | M · Option Exercise | +2K | — | — | 2.5% | 79.96K | 81.96K |
| Common Stock Direct | 1/30/2026 | M · Option Exercise | +3.75K | — | — | 4.6% | 81.96K | 85.71K |
| Common Stock Direct | 1/30/2026 | M · Option Exercise | +2.86K | — | — | 3.3% | 85.71K | 88.57K |
| Common Stock Direct | 1/30/2026 | S · Sale | −4.80K | $16.58 | $79.55K | 5.4% | 88.57K | 83.77K |
| Common Stock Direct | 1/30/2026 | S · Sale | −98.00 | $17.37 | $1.70K | 0.1% | 83.77K | 83.67K |
| Total | +6.92K | -$81.25K | ||||||
Restricted Stock Units
Common Stock
3.21K shares
Shares
−3.21K
Strike price
0
Held after
0.00
Exercisable
—
Restricted Stock Units
Common Stock
2K shares
Shares
−2K
Strike price
0
Held after
2K
Exercisable
—
Restricted Stock Units
Common Stock
3.75K shares
Shares
−3.75K
Strike price
0
Held after
18.75K
Exercisable
—
Restricted Stock Units
Common Stock
2.86K shares
Shares
−2.86K
Strike price
0
Held after
25.73K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.21K shares | 1/30/2026 | M · Option Exercise | −3.21K | 0 | — | 0.00 |
| Restricted Stock Units Direct | Common Stock2K shares | 1/30/2026 | M · Option Exercise | −2K | 0 | — | 2K |
| Restricted Stock Units Direct | Common Stock3.75K shares | 1/30/2026 | M · Option Exercise | −3.75K | 0 | — | 18.75K |
| Restricted Stock Units Direct | Common Stock2.86K shares | 1/30/2026 | M · Option Exercise | −2.86K | 0 | — | 25.73K |